Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. - Wikidata - thesis-toulmin - TriplyDB

Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.

Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.

http://www.wikidata.org/entity/Q35848867

about

Targeting the molecular and cellular interactions of the bone marrow niche in immunologic disease The hematopoietic chemokine CXCL12 promotes integration of human endothelial colony forming cell-derived cells into immature vessel networks CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand Chemokine-mobilized adult stem cells; defining a better hematopoietic graft.Targeted antagonism of CXCR4 mobilizes progenitor cells under investigation for cardiovascular disease.Combinatorial G-CSF/AMD3100 treatment in cardiac repair after myocardial infarction.Human endothelial stem/progenitor cells, angiogenic factors and vascular repair.E-selectin mediated adhesion and migration of endothelial colony forming cells is enhanced by SDF-1α/CXCR4.G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice.Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.Increased yield of endothelial cells from peripheral blood for cell therapies and tissue engineering.Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect Continuous AMD3100 Treatment Worsens Renal Fibrosis through Regulation of Bone Marrow Derived Pro-Angiogenic Cells Homing and T-Cell-Related Inflammation.Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy.Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering.Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension.Effect of low-dose ritonavir on the pharmacokinetics of the CXCR4 antagonist AMD070 in healthy volunteers.Stem cell recruitment after injury: lessons for regenerative medicine.Bone marrow endothelial progenitors in atherosclerotic plaque resolution Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.The promise of cell-based therapies for diabetic complications: challenges and solutions Bone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunction.Advances in mobilization for the optimization of autologous stem cell transplantation.Cellular therapy for repair of cardiac damage after acute myocardial infarction A novel molecule Me6TREN promotes angiogenesis via enhancing endothelial progenitor cell mobilization and recruitment.Progenitor cell mobilization and recruitment: SDF-1, CXCR4, α4-integrin, and c-kit.Physiology and pharmacology of plerixafor.Circulating fibrocyte mobilization in negative pressure wound therapy.The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis.Synergistic vasculogenic effects of AMD3100 and stromal-cell-derived factor-1α in vasa nervorum of the sciatic nerve of mice with diabetic peripheral neuropathy.MSC-derived cytokines repair radiation-induced intra-villi microvascular injury.G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts.Substance P enhances EPC mobilization for accelerated wound healing.Combination of granulocyte colony-stimulating factor and CXCR4 antagonist AMD3100 for effective harvest of endothelial progenitor cells from peripheral blood and in vitro formation of primitive endothelial networks.

P2860

Q26865498-04B530F0-9D57-4415-B2DD-7F86ACCD6D44 Q27307132-774C43A2-86CB-4552-95A9-04DB6BFE45F5 Q28587353-BAB00312-B230-40F4-A24C-F92C648B9DD4 Q33589591-04AC5036-855A-4F9D-8345-C554C89C4493 Q33623545-DF4C7BA4-0FAD-4118-ADC7-551E17504E2C Q33925035-28320743-6609-451B-8E73-08005E9EAE1F Q34046814-8AEB5136-33F0-42B2-8EFB-3D523561F9D0 Q34333348-9267AC11-821D-4892-B2B7-43FDBBEC2725 Q34658637-E50E09A2-F24B-40B9-A53C-B51FB1CC5062 Q35230245-7BE6A69B-3BE3-44D2-80FB-9FEF7A6AFB73 Q35748620-9DBA666C-BE9D-4D9F-9590-17C2C05C6A54 Q35793034-771B3680-D342-4972-9F46-20F973DFCB55 Q35810984-66B1E1C1-D590-4767-83E3-2604B6CBCAAC Q35919102-FF9E4D53-7337-4A32-B470-684B4CCEF67D Q35930523-88F3AFC5-09FE-4774-AE42-86872CCEB2F3 Q36114568-5BE18E22-D019-4D8B-806D-11D35DE311D7 Q36428933-AD285499-D7DA-4BEE-9549-52654310F272 Q36445393-13ECAD75-40B1-4131-B0B9-E9FC565085A0 Q36482251-7C15A7B5-0BA1-409C-B97C-9B876337334B Q36593820-8FBAE0B3-D69F-4DD3-B01A-1E6F96493661 Q36599286-E5FACF46-58D6-4ACF-9631-6AFDB987889E Q36906139-870FB6B5-462F-4DE0-87CC-CD19A7F19628 Q37262399-89E25420-6A84-4F6A-98E2-C10A3F0FC67E Q37276042-F155EF8D-F996-4A92-9F6A-7AACE47FFBD3 Q37385637-4E8E4237-AFF2-44EA-9194-3C3BDEF45F07 Q37551715-3060BBA5-519E-40EA-9AAA-FC710372BD52 Q37687140-FA5D7BAB-E41B-402E-A11A-C5BBE0C7956B Q37743869-250FEF20-9964-49CC-8601-1445C93424BB Q38037185-0D1CE38D-73AF-4BA0-8795-94C394D22DF2 Q38157897-ACE1F879-E642-49CF-A922-7C91255F32B9 Q41241200-AA7DE2C9-CE1F-4180-A4A1-928E7A330337 Q42411644-7FF2E386-496A-4811-B7CC-7414334F854B Q46061259-D401742B-C0CA-470E-A35E-8C71E986ED21 Q47165775-CE744ECB-EBA2-442D-9BAC-932E92D80A26 Q47174627-6CC8AC01-BDC0-44B7-9506-D41DFB952110 Q48265780-CE90F1F1-931A-41FE-B7B8-DAB08898964B Q53401913-BB844A00-C2B3-43DC-A62F-A89C5A4F39C5

P2860

Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.

http://www.wikidata.org/entity/Q35848867

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Angiogenic cells can be rapidl ...... lowing treatment with AMD3100.

@ast

Angiogenic cells can be rapidl ...... lowing treatment with AMD3100.

@en

type

label

Angiogenic cells can be rapidl ...... lowing treatment with AMD3100.

@ast

Angiogenic cells can be rapidl ...... lowing treatment with AMD3100.

@en

prefLabel

Angiogenic cells can be rapidl ...... lowing treatment with AMD3100.

@ast

Angiogenic cells can be rapidl ...... lowing treatment with AMD3100.

@en

P1433

Q35848867-AC325CAC-1001-4187-BD3B-003255573A11

P1476

Q35848867-F560C456-A7AC-4EF0-8077-486D4F309203

P2093

Q35848867-05BCA79D-C8F4-4DB0-8F37-4630A4B3DA47

Q35848867-08BFA6F1-8F64-45E6-8681-2AF633F65031

Q35848867-44EC72D6-BB6B-461F-9232-FB44CB11FDCF

Q35848867-6184EE53-097F-49A2-90B9-428187F057B2

Q35848867-C89DE820-C670-4857-953E-8C6395792B0F

Q35848867-DC033EA3-EEB7-460E-9F7A-9FABE93B32A5

Q35848867-E4A16CCD-BC66-466A-B1F5-33610D63478B

P2860

Q35848867-0DCA2511-5CD3-4167-AAAB-DF522CEFE6A4

Q35848867-15AD7646-BB8E-4635-9F71-7B9CB3352F8E

Q35848867-180E9F03-D2AF-4CAC-9860-11DD55E5418C

Q35848867-21D20C55-B1F4-4E6B-A57B-E0557CE89221

Q35848867-2663DD10-FD8C-4B32-AE99-8EC956409C73

Q35848867-292BA996-BBD1-4E05-B8AF-4A03D1504543

Q35848867-2AA4C622-4EED-4AE3-8E70-9427796AB3A1

Q35848867-30412654-C6B4-4119-A8FE-4CB504FD2E77

Q35848867-3271ACDE-914D-43E5-B40F-32FE601806FD

Q35848867-38839D1C-189A-4F51-A1C3-A2CBC7D951E6

P304

Q35848867-CB3F9069-B232-4C67-9E84-A527A82998E3

P31

Q35848867-F6DE06A3-F951-41D4-91D6-D311F327C4B3

P356

Q35848867-3396CDBA-12D0-46C7-B50E-505200C9D80F

P407

Q35848867-D0E24049-53E7-4082-9A60-89E42F387B0E

P433

Q35848867-8A84B780-5DDD-46CC-B7CB-21152B8E047E

P478

Q35848867-3DC708D9-EC5C-47DC-9F10-56CF71D1E933

P577

Q35848867-94A8FF35-262F-4AA9-A082-FA0ABCD64CF6

P5875

Q35848867-F3273392-F376-4738-BD7D-E4BE002E79ED

P698

Q35848867-EB63A095-3455-401C-9202-0DD417C45ED9

P932

Q35848867-AC4DA337-387C-4DC1-AFE1-8BFB0212267E

P356

BLOOD-2006-06-030577

P1433

P1476

Angiogenic cells can be rapidl ...... lowing treatment with AMD3100.

@en

P2093

Benjamin J Capoccia

http://www.w3.org/2001/XMLSchema#string

Daniel C Link

http://www.w3.org/2001/XMLSchema#string

David Ingram

http://www.w3.org/2001/XMLSchema#string

John Dipersio

http://www.w3.org/2001/XMLSchema#string

Kathryn M Trinkaus

http://www.w3.org/2001/XMLSchema#string

Rebecca M Shepherd

http://www.w3.org/2001/XMLSchema#string

Steven M Devine

http://www.w3.org/2001/XMLSchema#string

P2860

Origins of circulating endothelial cells and endothelial outgrowth from blood

Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI)

Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders

Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood

Isolation of putative progenitor endothelial cells for angiogenesis

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.

Mouse model of angiogenesis

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction.

Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.

P304

3662-3667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2006-06-030577

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6875828

http://www.w3.org/2001/XMLSchema#string

P698

16912220

http://www.w3.org/2001/XMLSchema#string

P932

1895468

http://www.w3.org/2001/XMLSchema#string